EVALUATION OF THE EFFECT AND SAFETY OF PONATINIB AS THIRD-LINE TREATMENT FOR PATIENTS WITH CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE

Conference paper > Summary Text · 2016

Authors: P. PATIR, Ayşegül UYSAL, M. DURAN, Nur SOYER, Filiz VURAL, Güray SAYDAM

7th International Eurasian Hematology Congress, Turkey, İstanbul, International, Verbal, Summary Text, 2016-2016, WoS, vol 49

View details